We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
(-0.91%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$92.9M |
| 2 |
Amazon
AMZN
|
+$62.6M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$46.3M |
| 4 |
VMEO
Vimeo
VMEO
|
+$33.1M |
| 5 |
UnitedHealth
UNH
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$49.9M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$43.5M |
| 3 |
Humana
HUM
|
+$36.6M |
| 4 |
Vipshop
VIPS
|
+$35.6M |
| 5 |
Brookfield
BN
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.6% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 10.46% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Urban Edge Properties
UE
$2.94B
| $2.42M | 0.01% |
132,446
| – | – |
|
302
Roper Technologies
ROP
$36.3B
| $2.39M | 0.01% |
5,361
+15
| +0.3% | +$7.19K |
|
303
Applied Materials
AMAT
$426B
| $2.39M | 0.01% |
18,559
+6,975
| +60% | +$947K |
|
304
Lockheed Martin
LMT
$134B
| $2.37M | 0.01% |
6,873
+399
| +6% | +$144K |
|
|
305
Vipshop
VIPS
$6.84B
| $2.35M | 0.01% |
210,806
-2,264,620
| -91% | -$35.6M |
|
306
iShares S&P 500 Value ETF
IVE
$48.9B
| $2.33M | 0.01% |
16,013
+15,734
| +5,639% | +$2.34M |
|
307
iShares Gold Trust
IAU
$63B
| $2.32M | 0.01% |
69,580
+536
| +0.8% | +$18.3K |
|
|
Y
308
DELISTED
Alleghany Corp
Y
| $2.24M | 0.01% |
3,595
| – | – |
|
309
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $2.24M | 0.01% |
24,481
| – | – |
|
|
NEXI
310
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $2.23M | 0.01% |
+5,886
| New | +$1.97M |
|
311
Immunic
IMUX
$182M
| $2.21M | 0.01% |
+25,000
| New | +$2.46M |
|
312
Stanley Black & Decker
SWK
$14.2B
| $2.19M | 0.01% |
12,514
| – | – |
|
313
Teledyne Technologies
TDY
$30.4B
| $2.17M | 0.01% |
5,060
| – | – |
|
314
Angi Inc
ANGI
$224M
| $2.17M | 0.01% |
17,583
-1,073
| -6% | -$123K |
|
315
Boston Properties
BXP
$11B
| $2.14M | 0.01% |
19,765
-822
| -4% | -$93.9K |
|
|
XYZ
316
Block Inc
XYZ
$45.9B
| $2.14M | 0.01% |
8,919
+84
| +1% | +$21.6K |
|
|
LOV
317
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $2.13M | 0.01% |
606,345
+465,000
| +329% | +$1.77M |
|
318
Nathan's Famous
NATH
$402M
| $2.12M | 0.01% |
34,600
| – | – |
|
319
Zoetis
ZTS
$31.6B
| $2.07M | 0.01% |
10,678
-101
| -0.9% | -$20.4K |
|
320
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $2.07M | 0.01% |
25,122
+5,375
| +27% | +$444K |
|
|
RPT
321
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.07M | 0.01% |
162,175
-2,000
| -1% | -$25.5K |
|
|
MRSN
322
DELISTED
Mersana Therapeutics
MRSN
| $2.06M | 0.01% |
+8,723
| New | +$2.55M |
|
323
NVR
NVR
$17.2B
| $2.04M | 0.01% |
424
+4
| +1% | +$20.3K |
|
324
Bilibili
BILI
$7.18B
| $2.03M | 0.01% |
30,655
| – | – |
|
325
eBay
EBAY
$48.6B
| $2M | 0.01% |
28,720
-76
| -0.3% | -$5.45K |
|
Similar funds
SAM
First Manhattan's Q3 2021 Portfolio in Review
As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
- First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
- First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
- First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
- First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
- First Manhattan opened 132 new positions and closed 93 in Q3 2021.
- First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.
Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.